$327 Million is the total value of Endurant Capital Management LP's 75 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 63.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DVA | Sell | DAVITA INC | $15,513,000 | -4.7% | 214,713 | -21.7% | 4.74% | -3.9% |
| WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $13,088,000 | +391.8% | 180,223 | +422.9% | 4.00% | +396.3% |
| AGN | Buy | ALLERGAN PLC | $12,512,000 | +50.8% | 76,491 | +89.0% | 3.82% | +52.2% |
| SBRA | Buy | SABRA HEALTH CARE REIT INC | $11,908,000 | -2.4% | 634,419 | +14.0% | 3.64% | -1.6% |
| MCK | Buy | MCKESSON CORP | $11,244,000 | +59.8% | 72,100 | +57.4% | 3.44% | +61.3% |
| DHR | Sell | DANAHER CORP DEL | $10,541,000 | -10.9% | 113,565 | -17.6% | 3.22% | -10.1% |
| MD | Buy | MEDNAX INC | $9,711,000 | +27.7% | 181,717 | +3.0% | 2.97% | +28.8% |
| HOLX | Buy | HOLOGIC INC | $9,527,000 | +151.6% | 222,844 | +115.9% | 2.91% | +153.9% |
| TVTY | Buy | TIVITY HEALTH INC | $9,458,000 | +15.3% | 258,757 | +28.7% | 2.89% | +16.3% |
| MDT | Buy | MEDTRONIC PLC | $9,392,000 | +335.4% | 116,315 | +319.3% | 2.87% | +339.0% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $8,522,000 | +91.1% | 38,656 | +69.8% | 2.60% | +92.8% |
| JNJ | Buy | JOHNSON & JOHNSON | $8,495,000 | +15.6% | 60,800 | +7.6% | 2.60% | +16.7% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $8,493,000 | +38.3% | 342,598 | +62.8% | 2.60% | +39.6% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $8,280,000 | -26.6% | 43,608 | -26.8% | 2.53% | -25.9% |
| ABT | Sell | ABBOTT LABS | $8,183,000 | -27.7% | 143,383 | -32.4% | 2.50% | -27.0% |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $7,969,000 | -35.2% | 570,425 | -22.0% | 2.44% | -34.6% |
| AET | Sell | AETNA INC NEW | $7,112,000 | -27.2% | 39,427 | -35.8% | 2.17% | -26.5% |
| EVHC | Buy | ENVISION HEALTHCARE CORP | $6,780,000 | +122.3% | 196,174 | +189.1% | 2.07% | +124.2% |
| WMGI | Buy | WRIGHT MED GROUP N V | $6,775,000 | +561.6% | 305,200 | +670.7% | 2.07% | +568.1% |
| CAH | Buy | CARDINAL HEALTH INC | $6,236,000 | +7.6% | 101,771 | +17.6% | 1.91% | +8.6% |
| BBH | Buy | VANECK VECTORS ETF TRbiotech etf | $6,217,000 | +19.5% | 49,899 | +28.6% | 1.90% | +20.5% |
| MRK | New | MERCK & CO INC | $5,970,000 | – | 106,100 | +100.0% | 1.82% | – |
| HRC | New | HILL ROM HLDGS INC | $5,580,000 | – | 66,200 | +100.0% | 1.71% | – |
| ESRX | Sell | EXPRESS SCRIPTS HLDG CO | $5,575,000 | -28.9% | 74,690 | -39.7% | 1.70% | -28.3% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $5,238,000 | -3.4% | 107,600 | +7.2% | 1.60% | -2.6% |
| ABC | Buy | AMERISOURCEBERGEN CORP | $5,072,000 | +81.7% | 55,240 | +63.7% | 1.55% | +83.2% |
| SHPG | Sell | SHIRE PLCsponsored adr | $5,072,000 | -40.1% | 32,696 | -40.9% | 1.55% | -39.6% |
| ANTM | Sell | ANTHEM INC | $5,065,000 | -18.7% | 22,511 | -31.4% | 1.55% | -18.0% |
| MYL | Sell | MYLAN N V | $5,030,000 | +22.0% | 118,887 | -9.5% | 1.54% | +23.1% |
| INCR | New | INC RESH HLDGS INCcl a | $4,922,000 | – | 112,900 | +100.0% | 1.50% | – |
| BIIB | Sell | BIOGEN INC | $4,906,000 | -60.6% | 15,399 | -61.3% | 1.50% | -60.3% |
| ENTL | Sell | ENTELLUS MED INC | $4,616,000 | +19.8% | 189,268 | -9.3% | 1.41% | +20.8% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $4,600,000 | -1.6% | 67,650 | +19.2% | 1.41% | -0.8% |
| BDX | Buy | BECTON DICKINSON & CO | $4,296,000 | +56.6% | 20,070 | +43.3% | 1.31% | +58.0% |
| CELG | Buy | CELGENE CORP | $3,945,000 | +66.0% | 37,800 | +131.9% | 1.21% | +67.5% |
| CVS | Buy | CVS HEALTH CORP | $3,864,000 | +72.8% | 53,300 | +93.8% | 1.18% | +74.4% |
| FATE | Buy | FATE THERAPEUTICS INC | $3,401,000 | +214.9% | 556,679 | +104.1% | 1.04% | +218.0% |
| LH | New | LABORATORY CORP AMER HLDGS | $3,282,000 | – | 20,575 | +100.0% | 1.00% | – |
| BAX | Buy | BAXTER INTL INC | $3,248,000 | +149.5% | 50,249 | +142.2% | 0.99% | +152.0% |
| FOLD | New | AMICUS THERAPEUTICS INC | $2,970,000 | – | 206,400 | +100.0% | 0.91% | – |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $2,956,000 | +15.3% | 29,900 | +39.7% | 0.90% | +16.3% |
| PTI | New | PROTEOSTASIS THERAPEUTICS IN | $2,828,000 | – | 485,012 | +100.0% | 0.86% | – |
| SYK | Sell | STRYKER CORP | $2,767,000 | -22.4% | 17,867 | -28.8% | 0.85% | -21.7% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $2,715,000 | -11.1% | 48,800 | -27.5% | 0.83% | -10.3% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $2,711,000 | -2.4% | 45,366 | -20.7% | 0.83% | -1.5% |
| MEDP | New | MEDPACE HLDGS INC | $2,288,000 | – | 63,100 | +100.0% | 0.70% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $2,105,000 | – | 5,600 | +100.0% | 0.64% | – |
| NVRO | Sell | NEVRO CORP | $1,861,000 | -48.1% | 26,961 | -31.7% | 0.57% | -47.6% |
| HUM | New | HUMANA INC | $1,687,000 | – | 6,800 | +100.0% | 0.52% | – |
| ARA | Sell | AMERICAN RENAL ASSOCIATES HO | $1,551,000 | +8.0% | 89,129 | -7.1% | 0.47% | +9.0% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $1,515,000 | +141.2% | 37,828 | +118.3% | 0.46% | +143.7% |
| ENDOLOGIX INCnote 2.250%12/1 | $1,476,000 | 0.0% | 1,541,000 | 0.0% | 0.45% | +0.9% | ||
| TCMD | New | TACTILE SYS TECHNOLOGY INC | $1,475,000 | – | 50,900 | +100.0% | 0.45% | – |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $1,377,000 | +8.4% | 12,216 | +5.2% | 0.42% | +9.4% |
| IMGN | Buy | IMMUNOGEN INC | $1,351,000 | +124.8% | 210,800 | +168.5% | 0.41% | +126.9% |
| RDUS | Buy | RADIUS HEALTH INC | $1,315,000 | +224.7% | 41,400 | +294.3% | 0.40% | +226.8% |
| MDCO | New | MEDICINES CO | $1,126,000 | – | 41,200 | +100.0% | 0.34% | – |
| VCRA | New | VOCERA COMMUNICATIONS INC | $982,000 | – | 32,500 | +100.0% | 0.30% | – |
| ANAB | Sell | ANAPTYSBIO INC | $977,000 | +13.6% | 9,700 | -60.6% | 0.30% | +14.6% |
| ALRN | Buy | AILERON THERAPEUTICS INC | $906,000 | -2.4% | 85,997 | +24.0% | 0.28% | -1.4% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $901,000 | – | 10,100 | +100.0% | 0.28% | – |
| AKTX | New | AKARI THERAPEUTICS PLCsponsored adr | $871,000 | – | 201,097 | +100.0% | 0.27% | – |
| ZGNX | New | ZOGENIX INC | $801,000 | – | 20,000 | +100.0% | 0.24% | – |
| INSM | Sell | INSMED INC | $714,000 | -76.0% | 22,910 | -76.0% | 0.22% | -75.8% |
| INCY | Sell | INCYTE CORP | $703,000 | -72.1% | 7,420 | -65.6% | 0.22% | -71.9% |
| PKI | New | PERKINELMER INC | $688,000 | – | 9,405 | +100.0% | 0.21% | – |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $667,000 | -75.3% | 4,950 | -73.2% | 0.20% | -75.0% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $648,000 | -42.1% | 50,600 | -44.4% | 0.20% | -41.6% |
| OMED | New | ONCOMED PHARMACEUTICALS INC | $570,000 | – | 139,100 | +100.0% | 0.17% | – |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $430,000 | – | 9,500 | +100.0% | 0.13% | – |
| CI | Sell | CIGNA CORPORATION | $406,000 | -87.0% | 2,000 | -88.0% | 0.12% | -86.9% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $382,000 | – | 17,600 | +100.0% | 0.12% | – |
| SPRO | New | SPERO THERAPEUTICS INC | $365,000 | – | 31,100 | +100.0% | 0.11% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $278,000 | – | 10,300 | +100.0% | 0.08% | – |
| DRNA | New | DICERNA PHARMACEUTICALS INC | $170,000 | – | 18,837 | +100.0% | 0.05% | – |
| GLYC | Exit | GLYCOMIMETICS INC | $0 | – | -17,607 | -100.0% | -0.08% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDsponsored adr | $0 | – | -18,133 | -100.0% | -0.10% | – |
| NLNK | Exit | NEWLINK GENETICS CORP | $0 | – | -36,100 | -100.0% | -0.11% | – |
| LCI | Exit | LANNET INC | $0 | – | -28,000 | -100.0% | -0.16% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -5,400 | -100.0% | -0.16% | – |
| XBI | Exit | SPDR SERIES TRUSTs&p biotech | $0 | – | -6,300 | -100.0% | -0.16% | – |
| XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -10,300 | -100.0% | -0.19% | – |
| ZSAN | Exit | ZOSANO PHARMA CORP | $0 | – | -827,297 | -100.0% | -0.21% | – |
| KITE | Exit | KITE PHARMA INC | $0 | – | -4,100 | -100.0% | -0.22% | – |
| NVTA | Exit | INVITAE CORP | $0 | – | -85,200 | -100.0% | -0.24% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -29,235 | -100.0% | -0.25% | – |
| HLS | Exit | HEALTHSOUTH CORP | $0 | – | -21,804 | -100.0% | -0.31% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -50,500 | -100.0% | -0.33% | – |
| ALDR | Exit | ALDER BIOPHARMACEUTICALS INC | $0 | – | -91,600 | -100.0% | -0.34% | – |
| ZBH | Exit | ZIMMER BIOMET HLDGS INC | $0 | – | -9,900 | -100.0% | -0.35% | – |
| DERM | Exit | DERMIRA INC | $0 | – | -65,015 | -100.0% | -0.53% | – |
| AGRX | Exit | AGILE THERAPEUTICS INC | $0 | – | -441,708 | -100.0% | -0.60% | – |
| RXDX | Exit | IGNYTA INC | $0 | – | -161,800 | -100.0% | -0.60% | – |
| HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -115,500 | -100.0% | -0.61% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -27,357 | -100.0% | -0.67% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -44,300 | -100.0% | -0.70% | – |
| ZTS | Exit | ZOETIS INCcl a | $0 | – | -39,500 | -100.0% | -0.76% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -109,300 | -100.0% | -0.80% | – |
| WAGE | Exit | WAGEWORKS INC | $0 | – | -51,100 | -100.0% | -0.94% | – |
| ANIP | Exit | ANI PHARMACEUTICALS INC | $0 | – | -59,900 | -100.0% | -0.95% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -21,900 | -100.0% | -1.01% | – |
| HSIC | Exit | SCHEIN HENRY INC | $0 | – | -41,900 | -100.0% | -1.04% | – |
| Exit | AMICUS THERAPEUTICS INCcall | $0 | – | -261,000 | -100.0% | -1.19% | – | |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -295,260 | -100.0% | -1.44% | – |
| BCR | Exit | BARD C R INC | $0 | – | -17,139 | -100.0% | -1.66% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -71,100 | -100.0% | -2.39% | – |
| PFE | Exit | PFIZER INC | $0 | – | -227,319 | -100.0% | -2.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.